Clinical Trial Update: MSC Intratissular Injection in Crohn Disease Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial from the University of Liege is evaluating an intratissular injection of mesenchymal stem cells for Crohn's disease, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• MSC intratissular injection (mesenchymal stem cells)

Snippet

Sponsor: University of Liege | Conditions: Efficacy and Safety | Phase 1, Phase 2 | Status: RECRUITING